Paradigm Biopharmaceuticals

Phase 3 Trial Update

Sign up to get the latest news, announcements and updates from Paradigm delivered straight to your inbox, and be the first to hear as our research advances.

Home

Contact

Announcements

Webinars

Corporate Governance

Analyst Reports

Market Data

Updates

[Header] Investors

Peer-Reviewed Publications

[Header] Science

Clinical Trials

Pipeline

About Paradigm

Executive Team

Our Board

[Header] Leadership

Archivo

Paradigm Senior Management provide an update on the Pivotal Phase 3 PARA_OA_012 Clinical Trial Progress following 100% enrolment.